InvestorsHub Logo
Followers 2
Posts 919
Boards Moderated 3
Alias Born 10/25/2024

Re: None

Tuesday, 11/12/2024 1:41:25 PM

Tuesday, November 12, 2024 1:41:25 PM

Post# of 30581
$CBDW -- Adnexus Biotechnologies Inc. is poised to revolutionize its HIV and infectious disease portfolio with the acquisition of Sanctum Therapeutics' leading-edge assets. https://finance.yahoo.com/news/1606-corp-target-strategic-investment-130000778.html
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.